CD34 and myelodysplastic syndrome: To get more insights into the molecular background of the DFX effect in MDS, we performed gene expression profiling of CD34+ hematopoietic progenitor cells obtained from untreated MDS patients and those who were given DFX and searched for cellular pathways affected by iron chelation.